Rosuvastatin for Primary Prevention Among Individuals With Elevated High-Sensitivity C-Reactive Protein and 5% to 10% and 10% to 20% 10-Year Risk
نویسندگان
چکیده
منابع مشابه
Rosuvastatin for primary prevention among individuals with elevated high-sensitivity c-reactive protein and 5% to 10% and 10% to 20% 10-year risk. Implications of the Justification for Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial for "intermediate risk".
BACKGROUND Recent primary prevention guidelines issued in Canada endorse the use of statin therapy among individuals at "intermediate risk" who have elevated levels of high-sensitivity C-reactive protein (hsCRP). However, trial data directly addressing whether this recommendation defines a patient population in which statin therapy is effective have not previously been published. METHODS AND ...
متن کاملdistributions of high-sensitivity c-reactive protein, total cholesterol-hdl ratio and 10-year cardiovascular risk: national population-based study
the present study aimed to evaluate the distributions of high-sensitivity c-reactive protein, tc-hdl ratio and 10-year risk of cardiovascular diseases among iranian adult population. we conducted a cross-sectional study on a total of 2125 adults aged 25 to 65. data of the third national surveillance of risk factors of non-communicable diseases (surfncd-2007) was used. anthropometric indices, bl...
متن کاملOffering statins to a population attending health checks with a 10-year cardiovascular disease risk between 10% and 20.
BACKGROUND In 2014 the UK National Institute for Health and Care Excellence recommended reducing the threshold for offering statin therapy to patients from a 10-year modelled risk of cardiovascular disease (CVD) of 20% to 10%. AIM To describe the response of patients in UK primary care with a CVD risk between 10% and 20% to an invitation to attend a consultation to discuss statins. DESIGN A...
متن کاملCitations to Australian Astronomy: 5 and 10 Year Benchmarks
Expanding upon Pimbblet’s informative 2011 analysis of career h-indices for members of the Astronomical Society of Australia, we provide additional citation metrics which are geared to a) quantifying the current performance of b) all professional astronomers in Australia. We have trawled the staff web-pages of Australian Universities, Observatories and Research Organisations hosting professiona...
متن کاملRosuvastatin in patients with elevated C-reactive protein.
To the Editor: Ridker et al. (Nov. 20 issue) report the results of Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER),1 which showed that rosuvastatin significantly reduced cardiovascular events in patients with elevated levels of C-reactive protein. However, broad application of their results in primary prevention is premature, since the...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Circulation: Cardiovascular Quality and Outcomes
سال: 2010
ISSN: 1941-7713,1941-7705
DOI: 10.1161/circoutcomes.110.938118